Rapidly progressive diabetes as the first manifestation of adenocarcinoma of the pancreas
DOI:
https://doi.org/10.32818/reccmi.a2n2a3Keywords:
diabetes mellitus , pancreatic cancerAbstract
We report a case of a 67 year old man, who was diagnosed of type 2 diabetes mellitus in a routine analysis, and treated with diet, exercise and metformin. Twelve months after, the glycemic control remained inadequate and developed cardinal symptoms (polyuria, polydipsia, asthenia and progressive 12 kg weight loss) requiring starting insulin therapy. An abdominal CT showed a pancreatic mass that after a percutaneous biopsy was classified as pancreatic adenocarcinoma. This case emphasizes the importance of new-onset diabetes rapidly progressive as a clue to the diagnosis of pancreatic cancer.
Downloads
Metrics
References
Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8: 773-83.
Key C. Cancer of the pancreas. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER survival monograph: cancer survival among adults: US SEER program, 1988-2001, patient and tumor characteristics. Bethesda: NationalCancerInstitute, 2007.
Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M: Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. British journal of cancer 2005, 92:2076-2083.
Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009; 10(1):88-95.
Chari ST, Liebson CL, de Andrade M, Rabe KG, Ransom JE,Petersen GM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005; 129: 504-11.
Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM,Chari ST. Prevalence and clinical profi le of pancreatic cancerassociated diabetes mellitus. Gastroenterology 2008; 134: 981-87.
Pelaez-Luna M, Takahashi N, Fletcher JG, Chari ST. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 2007;102: 2157-63.
Permert J, Larsson J, Fruin AB, et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997; 15: 60-68.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Francisca Beatriz Rivas-Sánchez, Estíbaliz Romero-Masa, María Rocío Pacheco-Yepes, Antonio Luis Cuesta-Muñoz, Ricardo Gómez-Huelgas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
